BSE · 530881
Arunjyoti Bio Ventures Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹8 Cr with net profit ₹1 Cr — a 7.44% net margin, versus -16.27% the period before.
Shareholding
As of 2026-06-30
- Promoter47.64%
- Public52.36%
20,483 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.55× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Packaging · ranked #39 of 92 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| INOX India Limited | ₹17,241 Cr | 229.14 | 15.42 | 23.07% | 16.25% |
| Garware Hi-Tech Films Limited | ₹15,855 Cr | 146.52 | 5.97 | 12.73% | 15.95% |
| EPL Limited | ₹7,438 Cr | 72.12 | 2.6 | 13.61% | 8.16% |
| AGI Greenpac Limited | ₹4,568 Cr | 39.6 | 1.9 | 14.61% | 13.19% |
| Polyplex Corporation Ltd. | ₹3,498 Cr | 77.81 | 0.83 | 1.06% | 0.63% |
| UFLEX Limited | ₹3,440 Cr | 10.38 | 0.42 | 3.9% | 2.11% |
| Xpro India Limited | ₹3,205 Cr | 166.93 | 4.22 | 2.53% | 3.81% |
| TCPL Packaging Limited | ₹2,863 Cr | 26.81 | 3.98 | 13.61% | 5.45% |
| Cosmo First Limited | ₹2,347 Cr | 62.79 | 1.45 | 9.48% | 4.61% |
| Mold-Tek Packaging Ltd. | ₹2,272 Cr | 35.7 | 4.81 | 13.93% | 10.08% |
| Arunjyoti Bio Ventures Limited(this company) | ₹96 Cr | — | 3.35 | -6.27% | -21.91% |
AI analysis
AI-generated · google/gemini-2.5-flashArunjyoti Bio Ventures Limited has a market capitalization of Rs 100 Cr. The company reported revenue of Rs 28.17 Cr, with a negative profit margin of -21.91%. Its book value stands at Rs 1.54, and it has a debt-to-equity ratio of 2.27. The company's 52-week high was Rs 12.71 and its 52-week low was Rs 4.98.
Positives
- None identified.
Negatives
- −The company reported a negative profit margin of -21.91%.
- −Return on Equity (ROE) is negative at -6.27%.
- −Return on Capital Employed (ROCE) is negative at -0.699%.
- −The debt-to-equity ratio is high at 2.27.
- −The company did not report any earnings per share (EPS) for the most recent period.
- −No quarterly results have been disclosed for periods after June 2026.
Financial Performance
Arunjyoti Bio Ventures Limited reported a revenue of Rs 28.17 Cr. The company's profit margin was negative at -21.91%. Earnings per share (EPS) for the recent period ended June 2026 was 0, reflecting the company's profitability challenges. Quarterly data shows fluctuations, with net profit ranging from Rs 2.05 Cr in June 2025 to a loss of Rs -5.4 Cr in March 2026.
Profitability & Returns
The company's profitability metrics indicate challenges, with a Return on Equity (ROE) of -6.27% and a Return on Capital Employed (ROCE) of -0.699%. The overall profit margin for the company was -21.91%. These figures highlight that the company is currently not generating positive returns from its equity or capital employed.
Balance Sheet
Arunjyoti Bio Ventures Limited has a book value of Rs 1.54. The company's debt-to-equity ratio is 2.27, indicating a significant reliance on debt financing relative to equity. This leverage can increase financial risk for the company.
Ownership & Pledges
As of June 30, 2026, the promoter holding in Arunjyoti Bio Ventures Limited was 47.6368%, while the public holding stood at 52.3632%. There is no reported promoter pledge, with the pledge percentage at 0%. No FII or DII holding was reported for this period.
Data as of — price: 2026-07-30 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Arunjyoti Bio Ventures Limitedshare price & fundamentals